Refine
Has Fulltext
- yes (165)
Year of publication
Document Type
- Journal article (165) (remove)
Keywords
- multiple sclerosis (9)
- B cells (7)
- Habichtskraut (7)
- EAE (6)
- MS (6)
- expression (6)
- inflammation (5)
- Bavaria (4)
- Biologie (4)
- ELISPOT (4)
- NPY (4)
- microglia (4)
- oligodendrocytes (4)
- 5-HT1A (3)
- 5-HT2C (3)
- Asteraceae (3)
- Bayern (3)
- Brombeere (3)
- CNS (3)
- Germany (3)
- Hieracium (3)
- Korbblütler (3)
- Ranunculus auricomus (3)
- Rubus (3)
- SGLT1 (3)
- Schleswig-Holstein (3)
- blood vessel (3)
- cancer (3)
- distribution (3)
- experimental autoimmune encephalomyelitis (3)
- induced pluripotent stem cells (3)
- mRNA (3)
- macrophages (3)
- mice (3)
- neurodegeneration (3)
- new species (3)
- organoid (3)
- relapse (3)
- Coexpression (2)
- Evolution (2)
- FGFR1 (2)
- Ficaria calthifolia (2)
- Ficaria verna (2)
- Franconia (2)
- Franken (2)
- GLUT2 (2)
- Karyotyp (2)
- Parkinson’s disease (2)
- Pflanzen (2)
- Systematik (2)
- TGFβ signaling (2)
- Trifolium micranthum (2)
- Unterfranken (2)
- Vegetation (2)
- Vorkommen (2)
- aging (2)
- anatomy (2)
- angiogenesis (2)
- animal models (2)
- bariatric surgery (2)
- brain (2)
- central nervous system (2)
- diabetes (2)
- diabetic nephropathy (2)
- diabetic retinopathy (2)
- differential expression (2)
- emphysema (2)
- extracellular matrix (2)
- heart (2)
- in vitro (2)
- inhibition (2)
- ischemia (2)
- lectotype (2)
- lesions (2)
- medical research (2)
- mitochondria (2)
- mouse (2)
- mucoepidermoid carcinoma (2)
- neuroinflammation (2)
- neurotrophins (2)
- new subspecies (2)
- organoids (2)
- oxidative stress (2)
- parotid gland (2)
- peroxisomes (2)
- photon-counting (2)
- pleomorphic adenoma (2)
- preclinical research (2)
- predictive value (2)
- regeneration (2)
- remyelination (2)
- retinitis pigmentosa (2)
- stroke (2)
- transgenic mice (2)
- translational research (2)
- triple in situ hybridization (2)
- tumor (2)
- tumor microenvironment (2)
- vasculogenesis (2)
- vegetation (2)
- 18F-FDG (1)
- 2C-values (1)
- 3D image analysis (1)
- A549 cell line (1)
- ADHD (1)
- AMD (1)
- ARF (1)
- ATF6 (1)
- AZD4547 (1)
- Agamospermy (1)
- Akt (1)
- Alemtuzumab (1)
- Alzheimers disease (1)
- Amrum (1)
- Amyotrophic-lateral-sclerosis (1)
- Apomixis (1)
- Art (1)
- Atlantischer Wildkohl (1)
- Autoimmunity (1)
- Axon degeneration (1)
- Axon growth (1)
- Axonal transport (1)
- BDNF (1)
- BSTA (1)
- Baumart (1)
- Bayerische Alpen (1)
- Bayern (Nord) (1)
- Berlin (1)
- Biodiversität (1)
- Blut-Hirn-Schranke (1)
- Boden (1)
- Bombesin ; Bombesin receptor ; Chromosomal localization (1)
- Botanische Nomenklatur (1)
- Brain (1)
- Brassica oleracea (1)
- Brombeerart (1)
- CD4 T cells (1)
- CD52 (1)
- CEA (1)
- CEACAM1 (1)
- CMV (1)
- COPD (1)
- COS cell expression (1)
- CPFE (1)
- CT angiography (1)
- CXCL12-abundant reticular (CAR)-cells (1)
- Cancellous bone (1)
- Cancer models (1)
- Cancer therapeutic resistance (1)
- Caryophyllaceae (1)
- Cell reprogramming (1)
- Cell therapy (1)
- Cells (1)
- Cerastium brachypetalum (1)
- Cerastium tenoreanum (1)
- ChAT (1)
- ChT1 (1)
- Chamaesyce (1)
- Chirurgie (1)
- Cone-beam computed tomography (1)
- Copaxone® (1)
- CreERT2 (1)
- Cx3cr1 (1)
- DAMGO (1)
- DNA methylation (1)
- DNA weight (1)
- DSG2 (1)
- Developmental biology (1)
- Drosophilia (1)
- Durchflusscytometrie (1)
- EBV (1)
- ECM (1)
- EEOS (1)
- ER stress (1)
- ER-Stress (1)
- ERK (1)
- Echinina (1)
- Elbow (1)
- Elbow joint (1)
- Ellenberg indicator value for light (1)
- Ellenberg indicator values ; Mixed mountain forest ; Niche model ; Phytosociological databank (1)
- Embryonic stem cell (1)
- Endoplasmic-Reticulum Stress (1)
- Enzyme-Linked Immunospot assay (ELISPOT) (1)
- Epidermal papillae (1)
- FGF (1)
- FGF/FGFR signalling (1)
- FGFR (1)
- FGFR signaling (1)
- FTY720 (1)
- Festuco-Brometea (1)
- Ficaria ambigua (1)
- G-protein-coupled receptor (1)
- GLUT1 (1)
- GLUT3 (1)
- GLUT4 (1)
- GLUT5 (1)
- Garchinger Heide (1)
- Genom (1)
- Glucosetransportproteine (1)
- Glutamatergic synapses (1)
- Gold-Hahnenfuß (1)
- Guinea-pig uterus (1)
- HCMV infection (1)
- Hahnenfuß (1)
- Hematopoietic Stem (1)
- Heme-regulated inhibitor (1)
- Hieracium auriculoides (1)
- Hieracium cymosum (1)
- Hieracium echioides (1)
- Hieracium lachenalii subsp. litocretaceum (1)
- Hieracium maculatum (1)
- Hieracium subrigidum (1)
- Hieracium swantevitii (1)
- Hornkraut (1)
- Hueter interval (1)
- Human Muse Cells (1)
- II type-2 receptor (1)
- IL-6 (1)
- IL6 (1)
- Immune tolerance (1)
- Intermediate filaments (1)
- KATP channel (1)
- Kettenblume (1)
- Klee (1)
- Kohl (1)
- Kuhblume (1)
- Küstenschutz (1)
- L cells (1)
- LINGO-1 (1)
- LPS (1)
- Lacking neurofilaments (1)
- Langhaariges Habichtskraut (1)
- Latrophilin (1)
- Lectotypus (1)
- Lower Francony (1)
- Löwenzahn <Taraxacum> (1)
- MAP kinase pathway (1)
- MK801 (1)
- MNV type 3 (1)
- Mactel 2 (1)
- Messenger-RNAs (1)
- Microtubules (1)
- Missense mutation (1)
- Mitomycin C (1)
- Morphology (1)
- Morphotype (1)
- Motoneuron disease (1)
- Mouse model (1)
- Multidetector computed tomography (1)
- Multiple sclerosis (1)
- Mycobacterium tuberculosis (1)
- Myokarditis (1)
- N-Myc (1)
- NF-kappa-B (1)
- NMDA-Antagonist (1)
- NMDA-Rezeptor (1)
- NMDAR (1)
- Nachtkerze <Gattung> (1)
- Nanog protein (1)
- Nelkengewächse (1)
- Neophyten <Botanik> (1)
- Netherlands (1)
- Neural Differentiation (1)
- Neurofilament (1)
- Neurotrophic factors (1)
- Niche model (1)
- Nomen novum (1)
- Nordtirol (1)
- Northern Bavaria (1)
- OXPHOS (1)
- Oct4 (1)
- Oenothera (1)
- Oenothera stucchii (1)
- PCDHGC3 (1)
- PET (1)
- PIK3R1 (1)
- PKB/Akt phosphorylation (1)
- PP2A (1)
- PSP (1)
- Peyer's patches (1)
- Phedimus middendorffianus, var. diffusus (1)
- Phedimus spurius subsp. oppositifolius (1)
- Phosphorylation (1)
- Phytosociological database (1)
- Pilosella macranthela (1)
- Pilosella ottonis (1)
- Plasma-membrane (1)
- Pluripotency (1)
- Progressive motor neuronopathy (1)
- Protein kinase B (1)
- Protein transduction (1)
- Pruno-Rubion sprengelii (1)
- Prunus (1)
- Quality-control (1)
- RAP (1)
- RNA sequencing (1)
- RNA-sequencing (1)
- ROS (1)
- Ranunculus (1)
- Ranunculus puberulus (1)
- Ranunculus sarntheinianus (1)
- Ranunculus suborbicularis (1)
- Ranunculus vertumnalis (1)
- Regeneration niche (1)
- Regulatory T cells (1)
- Relapsing-remitting MS (1)
- Rhamno-Prunetea (1)
- Rictor-mTOR complex (1)
- Rosaceae (1)
- Rosengewächse (1)
- Rubella virus (1)
- Rubus L. sectio Corylifolii (1)
- Rubus boreofrisicus (1)
- Rubus phylloglotta (1)
- Rubus pseudoglotta (1)
- Rubus section (1)
- Rubus viridilucidus (1)
- Rv3034c (1)
- SAP47 gene (1)
- SARS-CoV-2 (1)
- SEMA3A (1)
- SLC2A3 (1)
- SP-fixation (1)
- Scanning electron microscopy (1)
- Schlaganfall (1)
- Schwann cells (1)
- Sea dikes (1)
- Sedum oppositifolium (1)
- Seedeich (1)
- Sektion Corylifolii (1)
- Senescence (1)
- Species novum (1)
- Spinal Muscular-arthropy (1)
- Stammzelle (1)
- Standortfaktor <Botanik> (1)
- Stat3 (1)
- Stathmin (1)
- Stem cells (1)
- Substance P receptor (1)
- Switzerland (1)
- Syap1 localization (1)
- Systematics (1)
- T cell assay (1)
- T cells (1)
- T-cadherin (1)
- TGF-beta (1)
- TGF-β1 (1)
- TLO (1)
- TNF-α (1)
- TTS (1)
- Taraxacum (1)
- Taraxacum cimae-gallinae spec. nov. (1)
- Taraxacum sect. Borealia (1)
- Targeted therapies (1)
- Taxonomie (1)
- Thüringen (1)
- Transcription factor NRF1 (1)
- Transgenic mice (1)
- Translation Initiation (1)
- Trifolium dubium (1)
- Trifolium ornithopodioides (1)
- Triple in situ hybridization (1)
- Tumour angiogenesis (1)
- Unterart (1)
- VAChT (1)
- VEGF (1)
- VPP mouse model (1)
- Verbreitung (1)
- Viability (1)
- WNT signaling (1)
- Weißtanne (1)
- X-ray computed (1)
- XBP1 (1)
- Y-gastric bypass (1)
- aPC (1)
- abdominal imaging (1)
- acceptance (1)
- acetylcholine (1)
- acetyltransferase (1)
- acinic cell carcinoma (1)
- activation (1)
- adenocarcinoma (1)
- adenoid cystic carcinoma (ACC) (1)
- adhesion GPCR (1)
- adhesion molecule-1 (1)
- adipose tissue (1)
- adipose-derived stromal cells (1)
- adventitia (1)
- age-related macular degeneration (1)
- age-related macular degeneration (AMD) (1)
- agricultural landscape (1)
- alpine Taraxaca (1)
- amygdala (1)
- anatomical landmark (1)
- angiotensin II (1)
- antibodies (1)
- anti‐aging (1)
- anxiety (1)
- aorta ring (1)
- aortic adventitia (1)
- apoptosis (1)
- assembloid (1)
- astrocytoma (1)
- atrial natriuretic peptide (1)
- autoimmunity (1)
- axonal damage (1)
- axonal degeneration (1)
- axonal injury (1)
- axons (1)
- beta-aminopropionitrile (1)
- bile duct (1)
- biliary glycoprotein CD66A (1)
- biliopancreatic diversion (1)
- biodiversity (1)
- bioprinting (1)
- blood coagulation (1)
- blood pressure (1)
- blood-brain barrier (1)
- blood-brain barrier (BBB) model (1)
- body weight (1)
- bone (1)
- bone marrow-derived monocytes (1)
- brain-retina axis (1)
- breast cancer (1)
- breast cancer cells (1)
- breast cancer model (1)
- brush cell (1)
- brush cells (1)
- c-Myc (1)
- cable-clamp implants (1)
- cadaver multiorgan preservation (1)
- cadherin-13 (CDH13) (1)
- calcareous grassland (1)
- calcitonin gene-related peptide (1)
- calcium (1)
- calcium channel antagonists (1)
- calodon (1)
- cancellous bone (1)
- cancer therapy (1)
- carcinoembryonic anitgen family (1)
- cardiac hyperthrophy (1)
- cardiomyocytes (1)
- cardiovascular MRI (1)
- catalase (1)
- caveolin-1 (1)
- cell adhesion (1)
- cell biology (1)
- cell culture (1)
- cell penetrating peptides (1)
- cells (1)
- cellular internalization (1)
- cerebEND (1)
- cerebellum (1)
- chemistry (1)
- chemotherapy (CH) (1)
- cholinergic (1)
- choroidal neovascularization (CNV) (1)
- chromatin (1)
- chronic kidney disease (1)
- chronic viral infection (1)
- ciliary neurotrophic factor (CNTF) (1)
- classification (1)
- climate (1)
- coexpression (1)
- computed tomography angiography (CTA) (1)
- contextual anxiety (1)
- continuous extracorporeal femoral perfusion model (1)
- contractility (1)
- convolution kernel (1)
- cortical pathology (1)
- cotransporter SGLT1 (1)
- cytokine secretion kinetics (1)
- cytokines (1)
- cytomegalovirus (1)
- cytotopes (1)
- dCIRL (1)
- dandelion (1)
- degeneration (1)
- demyelination (1)
- dendric cells (1)
- desmosomal cadherins (1)
- determination key (1)
- developmental biology (1)
- dexamethasone (1)
- diabetes mellitus (1)
- diagnostic markers (1)
- digital subtraction angiography (DSA) (1)
- dilated cardiomyopathy with ataxia (1)
- direct anterior approach (1)
- disability (1)
- disease (1)
- distinction (1)
- distribution range (1)
- diversity (1)
- dorsal raphe (1)
- dovitinib (1)
- drug transport (1)
- duodenal jejunal bypass (1)
- ecology (1)
- editorial (1)
- electron microscopy (1)
- elispot (1)
- embryonic stem cells (1)
- endothelial cell infection (1)
- enteroendocrine cells (1)
- enzyme-linked immunoassays (1)
- epithelial cells (1)
- epithelial salivary gland (1)
- euchaetium (1)
- ex-arable field (1)
- exhaustion (1)
- experimental models of disease (1)
- extinction (1)
- extracellular matrix disorganisation (1)
- extracorporeal membrane oxygenation (1)
- extrusion of hiMPC-containing bioinks alginate + collagen type I (1)
- factor XII (1)
- factor binding profiles (1)
- fallax (1)
- false tongue-leaf blackberry (1)
- fatty acid (1)
- fear conditioning (1)
- femoral arteries (1)
- fentanyl (1)
- ferroptosis (1)
- fingolimod (1)
- flora (1)
- food intake (1)
- fracture (1)
- fructose intolerance (1)
- functional characterization (1)
- gall bladder (1)
- gene expression (1)
- gene locus (1)
- genetics (1)
- genome (1)
- genome size (1)
- glioblastoma multiforme (1)
- glioma (1)
- glucagon like peptide-1 (1)
- glucagon-like peptide-1 (GLP-1) (1)
- glucocorticoid receptor (1)
- glucokinase (1)
- glucose transporter (1)
- glucose-galactose malabsorption (1)
- glucosetransporter (1)
- glut1 (1)
- growth-factor (1)
- gut bacteria (1)
- gut hormones (1)
- hACE2 (1)
- hcv infection (1)
- heart failure (1)
- heart-brain axis (1)
- hematopoietic (1)
- hematopoietic stem cells (1)
- hiPSC-CM (1)
- high contrast (1)
- hip replacement (1)
- histone H1 (1)
- homebox genes (1)
- homeodomain transcription factors (1)
- human (1)
- human cytomegalovirus (HCMV) (1)
- human endothelial cells (1)
- human iPSC-derived mesodermal cells (hiMPCs) (1)
- human induced pluripotent stem cells (1)
- human induced pluripotent stem cells (hiPSCs)human induced pluripotent stem cells (hiPSCs) (1)
- human neurons (1)
- human osteosarcoma xenografts (1)
- hyaluronic acid (1)
- hypertonic solution (1)
- hypoxia (1)
- hypoxia inducible factor 1 (1)
- iconography (1)
- immune response (1)
- immunofluorescence (1)
- immunohistochemistry (1)
- immunosenescence (1)
- immunotherapy (1)
- in-situ hybridization (1)
- induced neural stem cells (1)
- inflammatory diseases (1)
- influenza virus ; virion RNA segments ; oligonucleotide mapping ; gene reassortment (1)
- innate immunity (1)
- insulin signaling (1)
- integrin α5β1 (1)
- integrin αvβ3 (1)
- interferon beta-1a (1)
- interleukin-1β (1)
- internalization (1)
- intestinal glucose (1)
- intestine (1)
- intraoperative radiotherapy (1)
- intravascular ultrasound (IVUS) (1)
- ischemic stroke (1)
- isosteviol sodium (STVNA) (1)
- karyotypes (1)
- large animal models (1)
- leukemia inhibitory factor (1)
- light sheet fluorescence microscopy (1)
- lipids (1)
- locus coeruleus (1)
- lung (1)
- lung fibrosis (1)
- macular neovascularization (1)
- malignancy (1)
- management (1)
- markers (1)
- mechanotransduction (1)
- megakaryocytes (1)
- membrane vesicles (1)
- memory cells (1)
- meninges (1)
- mesenchymal stem cells (1)
- mesenchymal stromal cells (1)
- mesodermal organoid (1)
- metabolism (1)
- metabotropic signalling (1)
- metastasis (1)
- microRNA (1)
- microvascular complications (1)
- microvasculature (1)
- microvessel permeability (1)
- mild hypothermia (1)
- minimally-invasive (1)
- model (1)
- molecular biology (1)
- monocytes (1)
- morphotypes (1)
- mouse models (1)
- mucociliary clearance (1)
- multilayered vessel wall with intimate, media and adventitia (1)
- multipotent fetal neural stem cells (fNSCs) (1)
- musculoskeletal system (1)
- mutations (1)
- myelin (1)
- myeloid (1)
- myeloid cells (1)
- myocardial infarction (1)
- myocarditis (1)
- natural history (1)
- neotype (1)
- nerve fibers (1)
- nervous system (1)
- neue Brombeerart (1)
- neural (1)
- neural crest (1)
- neural organoid (1)
- neuro-/photoreceptor degeneration (1)
- neurodevelopment (1)
- neuroimmunology (1)
- neuroprotection (1)
- neuroprotective pathways (1)
- neurovascular unit in vitro (1)
- new Rubus species (1)
- new name (1)
- nicotinic acetylcholine receptors (1)
- nonneuronal acetylcholine (1)
- noradrenaline (1)
- novel human cadaveric perfusion model (1)
- occurrence (1)
- open-access database (1)
- optical clearing (1)
- p27(KIP1) (1)
- pancreatic cancer (1)
- pathology (1)
- pemphigus vulgaris (1)
- penetratin (1)
- perforator (1)
- peripheral nerve (1)
- peripheral nervous system (1)
- peroxisome (1)
- persistant infection (1)
- personalized treatment (1)
- phenotype (1)
- phosphatidylinositol (1)
- phosphocholine (1)
- photon-counting computed tomography (CT) (1)
- pig (1)
- podocytes (1)
- positron emission tomography (1)
- post-mortem heart recovery (1)
- prefrontal cortex (1)
- probe level data (1)
- progenitor (1)
- progenitor cells (1)
- proliferation (1)
- protein (1)
- protein phosphorylation (1)
- protein synthesis (1)
- psychiatric disorders (1)
- psychology (1)
- pubic symphysis (1)
- pulmonary hypertension (1)
- radial glia (1)
- radiation (1)
- radiotherapy (1)
- rat heart (1)
- reactive oxygen species (1)
- recurrence (1)
- regulation (1)
- reorganization (1)
- reprogramming (1)
- research infrastructure (1)
- reserpinized rat model (1)
- resident CD34-positive cells (1)
- retina (1)
- retinal angiomatous proliferation (1)
- salivary (1)
- salivary gland (1)
- salivary gland tumors (1)
- sasculature (1)
- scanning electron micrographs (1)
- secretion (1)
- self-renewal (1)
- sensory ganglia (1)
- sensory neuron (1)
- sensory physiology (1)
- sepsis (1)
- serial block face EM (1)
- series Discolores (1)
- series Vestiti (1)
- serotonergic system (1)
- serotonin (1)
- sglt1 (1)
- signaling (1)
- signature (1)
- single‐cell RNA‐seq (1)
- small intestine (1)
- small pixel effect (1)
- sodium channels (1)
- soil nutrients (1)
- solid tumors (1)
- spectral shaping (1)
- spheroids (1)
- spinal cord (1)
- stem cell therapy (1)
- stroma (1)
- suppressor cells (1)
- synapse (1)
- synaptic vesicles (1)
- taste (1)
- taste receptor cells (1)
- taxonomy (1)
- tin prefiltration (1)
- tomography (1)
- topsoil removal (1)
- tracer (1)
- transcapillary pressure gradient (1)
- transcription-3 (STAT3) (1)
- transinteraction (1)
- transmission electron microscopy (1)
- tremor (1)
- trial (1)
- tube formation (1)
- tuft cells (1)
- tumor spheroids (1)
- tumor-vessel wall-interface model (1)
- tumorigenic properties (1)
- tumors (1)
- ultra-low-dose CT (1)
- ultrahigh resolution (1)
- ultrahigh-field MRI (1)
- ultrastructure (1)
- unfolded protein response (1)
- urinary calculi (1)
- vagus nerve stimulation (1)
- vascular biofabrication (1)
- vascular network and hierarchical organized vessels (1)
- vascular normalization (1)
- vascular structure (1)
- vascular wall stem and progenitor cells (1)
- vascularization model (1)
- vasculature (1)
- vesicular acetylcholine transporter (1)
- viability (1)
- white matter (1)
- xerostomia (1)
- µ-Opioid receptor (1)
- Ökologie (1)
- Österreich (1)
Institute
- Institut für Anatomie und Zellbiologie (165) (remove)
Sonstige beteiligte Institutionen
- Naturalis Biodiversity Centre (2)
- Department of Biomedical Imaging, National Cerebral and Cardiovascular Research Center, Suita, Japan (1)
- Division of Medical Technology and Science, Department of Medical Physics and Engineering, Course of Health Science, Osaka University Graduate School of Medicine, Suita Japan (1)
- Institut for Molecular Biology and CMBI, Department of Genomics, Stem Cell Biology and Regenerative Medicine, Leopold-Franzens-University Innsbruck, Innsbruck, Austria (1)
- Johns Hopkins School of Medicine (1)
- Johns Hopkins School of Medicine, The Russell H Morgan Department of Radiology and Radiological Science, Baltimore, MD, USA (1)
Results are presented of cloning cDNA of procine growth hormone, analysis of its primary structure, and creation of a construction capable of expression of this cDNA in Esqheriahia coti cells. It is shown that in the population of mRNA coding porcine growth hormone, heterogeneity is noted which is manifested not only at the level of the nucleotide sequence, but also is reflected in the amino acid sequence of the mature hormone.
Besides external characteristics and reading a piece of DNA (barcode), the DNA weight per nucleus (genome size) via flow cytometry is a key value to detect species and hybrids and determine ploidy. In addition, the DNA weight appears to be related to various properties, such as the size of the cell and the nucleus, the duration of mitosis and meiosis and the generation time. Sometimes it is even possible to distinguish between groups or sections, which can lead to new classification of the genera. The variation in DNA weight is also useful to analyze biodiversity, genome evolution and relationships between related taxa. Moreover, it is important to know how large a genome is before one determines the base sequence of the DNA of a plant. Flow cytometry is also important for understanding fundamental processes in plants such as growth and development and recognizing chimeras. In the literature, DNA weight measurements are usually limited to one genus and often only locally (Siljak et al. 2010; Bai et al. 2012). In this study, however, it was decided to investigate all vascular plants from one country. This can also contribute to the protection of rare plants. This study is the first flora in the world whose weight of DNA per nucleus and peak patterns has been determined. More than 6400 plants, representing more than 2350 (sub)species (more than 90%) have been collected, thanks to the help of almost 100 volunteers of Floristisch Onderzoek Nederland (Floron). Multiple specimens of many species have therefore been measured, preferably from different populations, in some cases more than fifty. For 1370 species, these values were not previously published. Moreover, a good number of the remaining 45% are new for The Netherlands. In principle, each species has a fixed weight of DNA per nucleus. It has also been found that, especially between the genera, there are strong differences in the number of peaks that determine the DNA weight, from one to five peaks. This indicates that in a plant or organ there are sometimes nuclei with multiples of its standard DNA weight (multiple ploidy levels). It is impossible to show graphs of more than 2350 species. Therefore, we have chosen to show the peak pattern in a new way in a short formula. Within most genera there are clear differences in the DNA weights per nucleus between the species, in some other genera the DNA weight is hardly variable. Based on about twenty genera that were previously measured completely in most cases (‘t Hart et al. 2003: Veldkamp and Zonneveld 2011; Soes et al. 2012; Dirkse et al. 2014, 2015; Verloove et al. 2017; Zonneveld [et al.] 2000−2018), it can be noted that even if all species of a genus have the same number of chromosomes, there can still be a difference of up to three times in the weight of the DNA. Therefore, a twice larger DNA weight does not have to indicate four sets of chromosomes. Finally, this research has also found clues to examine further the current taxonomy of a number of species or genera.
Neurofilament depletion improves microtubule dynamics via modulation of Stat3/stathmin signaling
(2016)
In neurons, microtubules form a dense array within axons, and the stability and function of this microtubule network is modulated by neurofilaments. Accumulation of neurofilaments has been observed in several forms of neurodegenerative diseases, but the mechanisms how elevated neurofilament levels destabilize axons are unknown so far. Here, we show that increased neurofilament expression in motor nerves of pmn mutant mice, a model of motoneuron disease, causes disturbed microtubule dynamics. The disease is caused by a point mutation in the tubulin-specific chaperone E (Tbce) gene, leading to an exchange of the most C-terminal amino acid tryptophan to glycine. As a consequence, the TBCE protein becomes instable which then results in destabilization of axonal microtubules and defects in axonal transport, in particular in motoneurons. Depletion of neurofilament increases the number and regrowth of microtubules in pmn mutant motoneurons and restores axon elongation. This effect is mediated by interaction of neurofilament with the stathmin complex. Accumulating neurofilaments associate with stathmin in axons of pmn mutant motoneurons. Depletion of neurofilament by Nefl knockout increases Stat3-stathmin interaction and stabilizes the microtubules in pmn mutant motoneurons. Consequently, counteracting enhanced neurofilament expression improves axonal maintenance and prolongs survival of pmn mutant mice. We propose that this mechanism could also be relevant for other neurodegenerative diseases in which neurofilament accumulation and loss of microtubules are prominent features.
3D cell culture models which closely resemble real human tissues are of high interest for disease modelling, drug screening as well as a deeper understanding of human developmental biology. Such structures are termed organoids. Within the last years, several human organoid models were described. These are usually stem cell derived, arise by self-organization, mimic mechanisms of normal tissue development, show typical organ morphogenesis and recapitulate at least some organ specific functions. Many tissues have been reproduced in vitro such as gut, liver, lung, kidney and brain. The resulting entities can be either derived from an adult stem cell population, or generated from pluripotent stem cells using a specific differentiation protocol. However, many organoid models only recapitulate the organs parenchyma but are devoid of stromal components such as blood vessels, connective tissue and inflammatory cells. Recent studies show that the incorporation of endothelial and mesenchymal cells into organoids improved their maturation and might be required to create fully functional micro-tissues, which will allow deeper insights into human embryogenesis as well as disease development and progression. In this review article, we will summarize and discuss recent works trying to incorporate stromal components into organoids, with a special focus on neural organoid models.
Organoids derived from human pluripotent stem cells are interesting models to study mechanisms of morphogenesis and promising platforms for disease modeling and drug screening. However, they mostly remain incomplete as they lack stroma, tissue resident immune cells and in particular vasculature, which create important niches during development and disease. We propose, that the directed incorporation of mesodermal progenitor cells (MPCs) into organoids will overcome the aforementioned limitations. In order to demonstrate the feasibility of the method, we generated complex human tumor as well as neural organoids. We show that the formed blood vessels display a hierarchic organization and mural cells are assembled into the vessel wall. Moreover, we demonstrate a typical blood vessel ultrastructure including endothelial cell-cell junctions, a basement membrane as well as luminal caveolae and microvesicles. We observe a high plasticity in the endothelial network, which expands, while the organoids grow and is responsive to anti-angiogenic compounds and pro-angiogenic conditions such as hypoxia. We show that vessels within tumor organoids connect to host vessels following transplantation. Remarkably, MPCs also deliver Iba1\(^+\) cells that infiltrate the neural tissue in a microglia-like manner.
Most humans become infected with human cytomegalovirus (HCMV). Typically, the immune system controls the infection, but the virus persists and can reactivate in states of immunodeficiency. While substantial information is available on the contribution of CD8 T cells and antibodies to anti-HCMV immunity, studies of the T\(_{H}\)1, T\(_{H}\)2, and T\(_{H}\)17 subsets have been limited by the low frequency of HCMV-specific CD4 T cells in peripheral blood mononuclear cell (PBMC). Using the enzyme-linked Immunospot\(^{®}\) assay (ELISPOT) that excels in low frequency measurements, we have established these in a sizable cohort of healthy HCMV controllers. Cytokine recall responses were seen in all seropositive donors. Specifically, interferon (IFN)-\({\gamma}\) and/or interleukin (IL)-17 were seen in isolation or with IL-4 in all test subjects. IL-4 recall did not occur in isolation. While the ratios of T\(_{H}\)1, T\(_{H}\)2, and T\(_{H}\)17 cells exhibited substantial variations between different individuals these ratios and the frequencies were relatively stable when tested in samples drawn up to five years apart. IFN-\({\gamma}\) and IL-2 co-expressing polyfunctional cells were seen in most subjects. Around half of the HCMV-specific CD4 cells were in a reversible state of exhaustion. The data provided here established the T\(_{H}\)1, T\(_{H}\)2, and T\(_{H}\)17 characteristic of the CD4 cells that convey immune protection for successful immune surveillance against which reactivity can be compared when the immune surveillance of HCMV fails.
There is a largely divergent body of literature regarding the relationship between Epstein-Barr virus (EBV) infection and brain inflammation in multiple sclerosis (MS). Here, we tested MS patients during relapse (n = 11) and in remission (n = 19) in addition to n = 22 healthy controls to study the correlation between the EBV- and brain-specific B cell response in the blood by enzyme-linked immunospot (ELISPOT) and enzyme-linked immunosorbent assay (ELISA). Cytomegalovirus (CMV) was used as a control antigen tested in n = 16 MS patients during relapse and in n = 35 patients in remission. Over the course of the study, n = 16 patients were untreated, while n = 33 patients received immunomodulatory therapy. The data show that there was a moderate correlation between the frequencies of EBV- and brain-reactive B cells in MS patients in remission. In addition we could detect a correlation between the B cell response to EBV and disease activity. There was no evidence of an EBV reactivation. Interestingly, there was also a correlation between the frequencies of CMV- and brain-specific B cells in MS patients experiencing an acute relapse and an elevated B cell response to CMV was associated with higher disease activity. The trend remained when excluding seronegative subjects but was non-significant. These data underline that viral infections might impact the immunopathology of MS, but the exact link between the two entities remains subject of controversy.
As soon as Peripheral Blood Mononuclear Cells (PBMC) are isolated from whole blood, some cells begin dying. The rate of apoptotic cell death is increased when PBMC are shipped, cryopreserved, or stored under suboptimal conditions. Apoptotic cells secrete cytokines that suppress inflammation while promoting phagocytosis. Increased numbers of apoptotic cells in PBMC may modulate T cell functions in antigen-triggered T cell assays. We assessed the effect of apoptotic bystander cells on a T cell ELISPOT assay by selectively inducing B cell apoptosis using α-CD20 mAbs. The presence of large numbers of apoptotic B cells did not affect T cell functionality. In contrast, when PBMC were stored under unfavorable conditions, leading to damage and apoptosis in the T cells as well as bystander cells, T cell functionality was greatly impaired. We observed that measuring the number of apoptotic cells before plating the PBMC into an ELISPOT assay did not reflect the extent of PBMC injury, but measuring apoptotic cell frequencies at the end of the assay did. Our data suggest that measuring the numbers of apoptotic cells prior to and post T cell assays may provide more stringent PBMC quality acceptance criteria than measurements done only prior to the start of the assay.
Clinical prognosis of metastasized colorectal carcinoma (CRC) is still not at desired levels and novel drugs are needed. Here, we focused on the multi-tyrosine kinase inhibitor E7080 (Lenvatinib) and assessed its therapeutic efficacy against human CRC cell lines in vitro and human CRC xenografts in vivo. The effect of E7080 on cell viability was examined on 10 humanCRCcell lines and humanendothelial cells (HUVEC). The inhibitory effect of E7080 on VEGF-induced angiogenesis was studied in an ex vivo mouse aortic ring angiogenesis assay. In addition, the efficacy of E7080 against xenografts derived fromCRC cell lines and CRC patient resection specimenswithmutated KRASwas investigated in vivo. Arelatively low cytotoxic effect of E7080 on CRC cell viabilitywas observed in vitro. Endothelial cells (HUVEC)weremore susceptible to the incubation with E7080. This is in line with the observation that E7080 demonstrated an anti-angiogenic effect in a three-dimensional ex vivo mouse aortic ring angiogenesis assay. E7080 effectively disrupted CRC cell-mediated VEGF-stimulated growth of HUVEC in vitro. Daily in vivo treatment with E7080 (5 mg/kg) significantly delayed the growth of KRAS mutated CRC xenografts with decreased density of tumor-associated vessel formations and without tumor regression. This observation is in line with results that E7080 did not significantly reduce the number of Ki67-positive cells in CRC xenografts. The results suggest antiangiogenic activity of E7080 at a dosage thatwas well tolerated by nudemice. E7080 may provide therapeutic benefits in the treatment of CRC with mutated KRAS.
Aims: Although mortality rate is very high, diagnosis of acute myocarditis remains challenging with conventional tests. We aimed to elucidate the potential role of longitudinal 2-Deoxy-2-\(^{18}\)F-fluoro-D-glucose (\(^{18}\)F-FDG) positron emission tomography (PET) inflammation monitoring in a rat model of experimental autoimmune myocarditis.
Methods and results: Autoimmune myocarditis was induced in Lewis rats by immunizing with porcine cardiac myosin emulsified in complete Freund’s adjuvant. Time course of disease was assessed by longitudinal \(^{18}\)F-FDG PET imaging. A correlative analysis between in- and ex vivo \(^{18}\)F-FDG signalling and macrophage infiltration using CD68 staining was conducted. Finally, immunohistochemistry analysis of the cell-adhesion markers CD34 and CD44 was performed at different disease stages determined by longitudinal \(^{18}\)F-FDG PET imaging. After immunization, myocarditis rats revealed a temporal increase in 18F-FDG uptake (peaked at week 3), which was followed by a rapid decline thereafter. Localization of CD68 positive cells was well correlated with in vivo \(^{18}\)F-FDG PET signalling (R\(^2\) = 0.92) as well as with ex vivo 18F-FDG autoradiography (R\(^2\) = 0.9, P < 0.001, respectively). CD44 positivity was primarily observed at tissue samples obtained at acute phase (i.e. at peak 18F-FDG uptake), while CD34-positive staining areas were predominantly identified in samples harvested at both sub-acute and chronic phases (i.e. at \(^{18}\)F-FDG decrease).
Conclusion: \(^{18}\)F-FDG PET imaging can provide non-invasive serial monitoring of cardiac inflammation in a rat model of acute myocarditis.
The parotid gland is one of the major salivary glands producing a serous secretion, and it plays an essential role in the digestive and immune systems. Knowledge of peroxisomes in the human parotid gland is minimal; furthermore, the peroxisomal compartment and its enzyme composition in the different cell types of the human parotid gland have never been subjected to a detailed investigation. Therefore, we performed a comprehensive analysis of peroxisomes in the human parotid gland’s striated duct and acinar cells. We combined biochemical techniques with various light and electron microscopy techniques to determine the localization of parotid secretory proteins and different peroxisomal marker proteins in parotid gland tissue. Moreover, we analyzed the mRNA of numerous gene encoding proteins localized in peroxisomes using real-time quantitative PCR. The results confirm the presence of peroxisomes in all striated duct and acinar cells of the human parotid gland. Immunofluorescence analyses for various peroxisomal proteins showed a higher abundance and more intense staining in striated duct cells compared to acinar cells. Moreover, human parotid glands comprise high quantities of catalase and other antioxidative enzymes in discrete subcellular regions, suggesting their role in protection against oxidative stress. This study provides the first thorough description of parotid peroxisomes in different parotid cell types of healthy human tissue.
A growing body of scientific evidence indicates that protein homeostasis, also designated as proteostasis, is causatively linked to chronic diabetic nephropathy (DN). Experimental studies have demonstrated that the insulin signaling in podocytes maintain the homeostatic unfolded protein response (UPR). Insulin signaling via the insulin receptor non-canonically activates the spliced X-box binding protein-1 (sXBP1), a highly conserved endoplasmic reticulum (ER) transcription factor, which regulates the expression of genes that control proteostasis. Defective insulin signaling in mouse models of diabetes or the genetic disruption of the insulin signaling pathway in podocytes propagates hyperglycemia induced maladaptive UPR and DN. Insulin resistance in podocytes specifically promotes activating transcription factor 6 (ATF6) dependent pathogenic UPR. Akin to insulin, recent studies have identified that the cytoprotective effect of anticoagulant serine protease-activated protein C (aPC) in DN is mediated by sXBP1. In mouse models of DN, treatment with chemical chaperones that improve protein folding provides an additional benefit on top of currently used ACE inhibitors. Understanding the molecular mechanisms that transmute renal cell specific adaptive responses and that deteriorate renal function in diabetes will enable researchers to develop new therapeutic regimens for DN. Within this review, we focus on the current understanding of homeostatic mechanisms by which UPR is regulated in DN.
Megakaryocytes (MKs) release platelets into the lumen of bone marrow (BM) sinusoids while remaining to reside within the BM. The morphogenetic events of this complex process are still not fully understood. We combined confocal laser scanning microscopy with transmission and serial block-face scanning electron microscopy followed by 3D-reconstruction on mouse BM tissue sections. These analyses revealed that MKs in close vicinity to BM sinusoid (BMS) wall first induce the lateral retraction of CXCL12-abundant reticular (CAR) cells (CAR), followed by basal lamina (BL) degradation enabling direct MK-sinusoidal endothelial cells (SECs) interaction. Subsequently, an endothelial engulfment starts that contains a large MK protrusion. Then, MK protrusions penetrate the SEC, transmigrate into the BMS lumen and form proplatelets that are in direct contact to the SEC surface. Furthermore, such processes are induced on several sites, as observed by 3D reconstructions. Our data demonstrate that MKs in interaction with CAR-cells actively induce BMS wall alterations, including CAR-cell retraction, BL degradation, and SEC engulfment containing a large MK protrusion. This results in SEC penetration enabling the migration of MK protrusion into the BMS lumen where proplatelets that are adherent to the luminal SEC surface are formed and contribute to platelet release into the blood circulation.
Contribution of adventitia-derived stem and progenitor cells to new vessel formation in tumors
(2021)
Blocking tumor vascularization has not yet come to fruition to the extent it was hoped for, as angiogenesis inhibitors have shown only partial success in the clinic. We hypothesized that under- appreciated vascular wall-resident stem and progenitor cells (VW-SPCs) might be involved in tumor vascularization and influence effectiveness of anti-angiogenic therapy. Indeed, in patient samples, we observed that vascular adventitia-resident CD34\(^+\) VW-SPCs are recruited to tumors in situ from co-opted vessels. To elucidate this in detail, we established an ex vivo model using concomitant embedding of multi-cellular tumor spheroids (MCTS) and mouse aortic rings (ARs) into collagen
gels, similar to the so-called aortic ring assay (ARA). Moreover, ARA was modified by removing the ARs’ adventitia that harbors VW-SPCs. Thus, this model enabled distinguishing the contribution of VW-SPCs from that of mature endothelial cells (ECs) to new vessel formation. Our results show that the formation of capillary-like sprouts is considerably delayed, and their number and network formation were significantly reduced by removing the adventitia. Substituting iPSC-derived neural spheroids for MCTS resulted in distinct sprouting patterns that were also strongly influenced by the
presence or absence of VW-SPCs, also underlying the involvement of these cells in non-pathological vascularization. Our data suggest that more comprehensive approaches are needed in order to block all of the mechanisms contributing to tumor vascularization.
A recombinant plasmid was constructed containing the gene for bovine growth hormone joinea with the regulatory region and the region coding the signal sequence of the Escherichia coli alkaline phosphatase gene. In conditions of phosphorus starvation, which c~s derepression of alkaline phosphatase, expression was shown of the gene for bovine growth hormone, in addition to partial processing and secretion of protein into periplasm.
Eine Reihe mehrtägiger Suchexkur-sionen / Transekte in verschiedene Regionen Bayerns in den Jahren 2011 bis 2014 waren der Gattung Taraxacum gewidmet. Unter den gesammelten und beobachteten Arten ist Taraxacum broddesonii (sect. Ruderalia / Taraxacum) neu für Deutschland. Neu für Bayern sind Taraxacum fusciflorum, marklundii, spiculatum (sect. Hamata) und Taraxacum acroglossum, atroviride, clarum, floccosum, freticola, glossodon, hemicyclum, homoschistum, infuscatum, intumescens, lacinulatum, leucopodum, lundense, ottonis, pallidipes, praestabile, pseudoretroflexum, pulverulentum, saxonicum, sellandii, sundbergii, uncidentatum, uniforme, violaceinervosum (sect. Ruderalia / Taraxacum). Taraxacum lojoënse wird als ältester und korrekter Name für T. lippertianum und T. matricium und wahrscheinlich auch für T. ampelophytum und T. debrayi angesehen. Seltenere Arten sind abgebildet.
Local axonal function of STAT3 rescues axon degeneration in the pmn model of motoneuron disease
(2012)
Axonal maintenance, plasticity, and regeneration are influenced by signals from neighboring cells, in particular Schwann cells of the peripheral nervous system. Schwann cells produce neurotrophic factors, but the mechanisms by which ciliary neurotrophic factor (CNTF) and other neurotrophic molecules modify the axonal cytoskeleton are not well understood. In this paper, we show that activated signal transducer and activator of transcription-3 (STAT3), an intracellular mediator of the effects of CNTF and other neurotrophic cytokines, acts locally in axons of motoneurons to modify the tubulin cytoskeleton. Specifically, we show that activated STAT3 interacted with stathmin and inhibited its microtubule-destabilizing activity. Thus, ectopic CNTF-mediated activation of STAT3 restored axon elongation and maintenance in motoneurons from progressive motor neuronopathy mutant mice, a mouse model of motoneuron disease. This mechanism could also be relevant for other neurodegenerative diseases and provide a target for new therapies for axonal degeneration.
Background:
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system (CNS) for which several new treatment options were recently introduced. Among them is the monoclonal anti-CD52 antibody alemtuzumab that depletes mainly B cells and T cells in the immune periphery. Considering the ongoing controversy about the involvement of B cells and in particular the formation of B cell aggregates in the brains of progressive MS patients, an in-depth understanding of the effects of anti-CD52 antibody treatment on the B cell compartment in the CNS itself is desirable.
Methods:
We used myelin basic protein (MBP)-proteolipid protein (PLP)-induced experimental autoimmune encephalomyelitis (EAE) in C57BL/6 (B6) mice as B cell-dependent model of MS. Mice were treated intraperitoneally either at the peak of EAE or at 60 days after onset with 200 μg murine anti-CD52 vs. IgG2a isotype control antibody for five consecutive days. Disease was subsequently monitored for 10 days. The antigen-specific B cell/antibody response was measured by ELISPOT and ELISA. Effects on CNS infiltration and B cell aggregation were determined by immunohistochemistry. Neurodegeneration was evaluated by Luxol Fast Blue, SMI-32, and Olig2/APC staining as well as by electron microscopy and phosphorylated heavy neurofilament serum ELISA.
Results:
Treatment with anti-CD52 antibody attenuated EAE only when administered at the peak of disease. While there was no effect on the production of MP4-specific IgG, the treatment almost completely depleted CNS infiltrates and B cell aggregates even when given as late as 60 days after onset. On the ultrastructural level, we observed significantly less axonal damage in the spinal cord and cerebellum in chronic EAE after anti-CD52 treatment.
Conclusion:
Anti-CD52 treatment abrogated B cell infiltration and disrupted existing B cell aggregates in the CNS.
Diabetes mellitus is a common disease affecting more than 537 million adults worldwide. The microvascular complications that occur during the course of the disease are widespread and affect a variety of organ systems in the body. Diabetic retinopathy is one of the most common long-term complications, which include, amongst others, endothelial dysfunction, and thus, alterations in the blood-retinal barrier (BRB). This particularly restrictive physiological barrier is important for maintaining the neuroretina as a privileged site in the body by controlling the inflow and outflow of fluid, nutrients, metabolic end products, ions, and proteins. In addition, people with diabetic retinopathy (DR) have been shown to be at increased risk for systemic vascular complications, including subclinical and clinical stroke, coronary heart disease, heart failure, and nephropathy. DR is, therefore, considered an independent predictor of heart failure. In the present review, the effects of diabetes on the retina, heart, and kidneys are described. In addition, a putative common microRNA signature in diabetic retinopathy, nephropathy, and heart failure is discussed, which may be used in the future as a biomarker to better monitor disease progression. Finally, the use of miRNA, targeted neurotrophin delivery, and nanoparticles as novel therapeutic strategies is highlighted.
Mouse embryonic stem cells (ESCs) are maintained in a naive ground state of pluripotency in the presence of MEK and GSK3 inhibitors. Here, we show that ground-state ESCs express low Myc levels. Deletion of both c-myc and N-myc (dKO) or pharmacological inhibition of Myc activity strongly decreases transcription, splicing, and protein synthesis, leading to proliferation arrest. This process is reversible and occurs without affecting pluripotency, suggesting that Myc-depleted stem cells enter a state of dormancy similar to embryonic diapause. Indeed, c-Myc is depleted in diapaused blastocysts, and the differential expression signatures of dKO ESCs and diapaused epiblasts are remarkably similar. Following Myc inhibition, pre-implantation blastocysts enter biosynthetic dormancy but can progress through their normal developmental program after transfer into pseudo-pregnant recipients. Our study shows that Myc controls the biosynthetic machinery of stem cells without affecting their potency, thus regulating their entry and exit from the dormant state.
Tumors are characterized by a rigid, highly cross-linked extracellular matrix (ECM), which impedes homogeneous drug distribution and potentially protects malignant cells from exposure to therapeutics. Lysyl oxidases are major contributors to tissue stiffness and the elevated expression of these enzymes observed in most cancers might influence drug distribution and efficacy. We examined the effect of lysyl oxidases on drug distribution and efficacy in 3D in vitro assay systems. In our experiments elevated lysyl oxidase activity was responsible for reduced drug diffusion under hypoxic conditions and consequently impaired cytotoxicity of various chemotherapeutics. This effect was only observed in 3D settings but not in 2D-cell culture, confirming that lysyl oxidases affect drug efficacy by modification of the ECM and do not confer a direct desensitizing effect. Both drug diffusion and efficacy were strongly enhanced by inhibition of lysyl oxidases. The results from the in vitro experiments correlated with tumor drug distribution in vivo, and predicted response to therapeutics in murine tumor models. Our results demonstrate that lysyl oxidase activity modulates the physical barrier function of ECM for small molecule drugs influencing their therapeutic efficacy. Targeting this process has the potential to significantly enhance therapeutic efficacy in the treatment of malignant diseases.
The mouse gastro-intestinal and biliary tract mucosal epithelia harbor choline acetyltransferase (ChAT)-positive brush cells with taste cell-like traits. With the aid of two transgenic mouse lines that express green fluorescent protein (EGFP) under the control of the ChAT promoter (EGFP\(^{ChAT}\)) and by using in situ hybridization and immunohistochemistry we found that EGFP\(^{ChAT}\) cells were clustered in the epithelium lining the gastric groove. EGFP\(^{ChAT}\) cells were numerous in the gall bladder and bile duct, and found scattered as solitary cells along the small and large intestine. While all EGFP\(^{ChAT}\) cells were also ChAT-positive, expression of the high-affinity choline transporter (ChT1) was never detected. Except for the proximal colon, EGFP\(^{ChAT}\) cells also lacked detectable expression of the vesicular acetylcholine transporter (VAChT). EGFP\(^{ChAT}\) cells were found to be separate from enteroendocrine cells, however they were all immunoreactive for cytokeratin 18 (CK18), transient receptor potential melastatin-like subtype 5 channel (TRPM5), and for cyclooxygenases 1 (COX1) and 2 (COX2). The ex vivo stimulation of colonic EGFP\(^{ChAT}\) cells with the bitter substance denatonium resulted in a strong increase in intracellular calcium, while in other epithelial cells such an increase was significantly weaker and also timely delayed. Subsequent stimulation with cycloheximide was ineffective in both cell populations. Given their chemical coding and chemosensory properties, EGFP\(^{ChAT}\) brush cells thus may have integrative functions and participate in induction of protective reflexes and inflammatory events by utilizing ACh and prostaglandins for paracrine signaling.
Ultra-high field cardiac MRI in large animals and humans for translational cardiovascular research
(2023)
A key step in translational cardiovascular research is the use of large animal models to better understand normal and abnormal physiology, to test drugs or interventions, or to perform studies which would be considered unethical in human subjects. Ultrahigh field magnetic resonance imaging (UHF-MRI) at 7 T field strength is becoming increasingly available for imaging of the heart and, when compared to clinically established field strengths, promises better image quality and image information content, more precise functional analysis, potentially new image contrasts, and as all in-vivo imaging techniques, a reduction of the number of animals per study because of the possibility to scan every animal repeatedly. We present here a solution to the dual use problem of whole-body UHF-MRI systems, which are typically installed in clinical environments, to both UHF-MRI in large animals and humans. Moreover, we provide evidence that in such a research infrastructure UHF-MRI, and ideally combined with a standard small-bore UHF-MRI system, can contribute to a variety of spatial scales in translational cardiovascular research: from cardiac organoids, Zebra fish and rodent hearts to large animal models such as pigs and humans. We present pilot data from serial CINE, late gadolinium enhancement, and susceptibility weighted UHF-MRI in a myocardial infarction model over eight weeks. In 14 pigs which were delivered from a breeding facility in a national SARS-CoV-2 hotspot, we found no infection in the incoming pigs. Human scanning using CINE and phase contrast flow measurements provided good image quality of the left and right ventricle. Agreement of functional analysis between CINE and phase contrast MRI was excellent. MRI in arrested hearts or excised vascular tissue for MRI-based histologic imaging, structural imaging of myofiber and vascular smooth muscle cell architecture using high-resolution diffusion tensor imaging, and UHF-MRI for monitoring free radicals as a surrogate for MRI of reactive oxygen species in studies of oxidative stress are demonstrated. We conclude that UHF-MRI has the potential to become an important precision imaging modality in translational cardiovascular research.
Adhesion-type G protein-coupled receptors (aGPCRs), a large molecule family with over 30 members in humans, operate in organ development, brain function and govern immunological responses. Correspondingly, this receptor family is linked to a multitude of diverse human diseases. aGPCRs have been suggested to possess mechanosensory properties, though their mechanism of action is fully unknown. Here we show that the Drosophila aGPCR Latrophilin/dCIRL acts in mechanosensory neurons by modulating ionotropic receptor currents, the initiating step of cellular mechanosensation. This process depends on the length of the extended ectodomain and the tethered agonist of the receptor, but not on its autoproteolysis, a characteristic biochemical feature of the aGPCR family. Intracellularly, dCIRL quenches cAMP levels upon mechanical activation thereby specifically increasing the mechanosensitivity of neurons. These results provide direct evidence that the aGPCR dCIRL acts as a molecular sensor and signal transducer that detects and converts mechanical stimuli into a metabotropic response.
Synapse-associated protein 1 (Syap1/BSTA) is the mammalian homologue of Sap47 (synapse-associated protein of 47 kDa) in Drosophila. Sap47 null mutant larvae show reduced short-term synaptic plasticity and a defect in associative behavioral plasticity. In cultured adipocytes, Syap1 functions as part of a complex that phosphorylates protein kinase B alpha/Akt1 (Akt1) at Ser\(^{473}\) and promotes differentiation. The role of Syap1 in the vertebrate nervous system is unknown. Here, we generated a Syap1 knock-out mouse and show that lack of Syap1 is compatible with viability and fertility. Adult knock-out mice show no overt defects in brain morphology. In wild-type brain, Syap1 is found widely distributed in synaptic neuropil, notably in regions rich in glutamatergic synapses, but also in perinuclear structures associated with the Golgi apparatus of specific groups of neuronal cell bodies. In cultured motoneurons, Syap1 is located in axons and growth cones and is enriched in a perinuclear region partially overlapping with Golgi markers. We studied in detail the influence of Syap1 knockdown and knockout on structure and development of these cells. Importantly, Syap1 knockout does not affect motoneuron survival or axon growth. Unexpectedly, neither knockdown nor knockout of Syap1 in cultured motoneurons is associated with reduced Ser\(^{473}\) or Thr\(^{308}\) phosphorylation of Akt. Our findings demonstrate a widespread expression of Syap1 in the mouse central nervous system with regionally specific distribution patterns as illustrated in particular for olfactory bulb, hippocampus, and cerebellum.
Blood vessel organoids are an important in vitro model to understand the underlying mechanisms of human blood vessel development and for toxicity testing or high throughput drug screening. Here we present a novel, cost-effective, and easy to manufacture vascular organoid model. To engineer the organoids, a defined number of human induced pluripotent stem cells are seeded in non-adhesive agarose coated wells of a 96-well plate and directed towards a lateral plate mesoderm fate by activation of Wnt and BMP4 signaling. We observe the formation of a circular layer of angioblasts around days 5–6. Induced by VEGF application, CD31\(^+\) vascular endothelial cells appear within this vasculogenic zone at approximately day 7 of organoid culture. These cells arrange to form a primitive vascular plexus from which angiogenic sprouting is observed after 10 days of culture. The differentiation outcome is highly reproducible, and the size of organoids is scalable depending on the number of starting cells. We observe that the initial vascular ring forms at the interface between two cell populations. The inner cellular compartment can be distinguished from the outer by the expression of GATA6, a marker of lateral plate mesoderm. Finally, 14-days-old organoids were transplanted on the chorioallantois membrane of chicken embryos resulting in a functional connection of the human vascular network to the chicken circulation. Perfusion of the vessels leads to vessel wall maturation and remodeling as indicated by the formation of a continuous layer of smooth muscle actin expressing cells enwrapping the endothelium. In summary, our organoid model recapitulates human vasculogenesis, angiogenesis as well as vessel wall maturation and therefore represents an easy and cost-effective tool to study all steps of blood vessel development and maturation directly in the human setting without animal experimentation.
Transcriptional and distributional profiling of microglia in retinal angiomatous proliferation
(2022)
Macular neovascularization type 3, formerly known as retinal angiomatous proliferation (RAP), is a hallmark of age-related macular degeneration and is associated with an accumulation of myeloid cells, such as microglia (MG) and infiltrating blood-derived macrophages (MAC). However, the contribution of MG and MAC to the myeloid cell pool at RAP sites and their exact functions remain unknown. In this study, we combined a microglia-specific reporter mouse line with a mouse model for RAP to identify the contribution of MG and MAC to myeloid cell accumulation at RAP and determined the transcriptional profile of MG using RNA sequencing. We found that MG are the most abundant myeloid cell population around RAP, whereas MAC are rarely, if ever, associated with late stages of RAP. RNA sequencing of RAP-associated MG showed that differentially expressed genes mainly contribute to immune-associated processes, including chemotaxis and migration in early RAP and proliferative capacity in late RAP, which was confirmed by immunohistochemistry. Interestingly, MG upregulated only a few angiomodulatory factors, suggesting a rather low angiogenic potential. In summary, we showed that MG are the dominant myeloid cell population at RAP sites. Moreover, MG significantly altered their transcriptional profile during RAP formation, activating immune-associated processes and exhibiting enhanced proliferation, however, without showing substantial upregulation of angiomodulatory factors.
Ischemic insults to the heart and brain, i.e., myocardial and cerebral infarction, respectively, are amongst the leading causes of death worldwide. While there are therapeutic options to allow reperfusion of ischemic myocardial and brain tissue by reopening obstructed vessels, mitigating primary tissue damage, post-infarction inflammation and tissue remodeling can lead to secondary tissue damage. Similarly, ischemia in retinal tissue is the driving force in the progression of neovascular eye diseases such as diabetic retinopathy (DR) and age-related macular degeneration (AMD), which eventually lead to functional blindness, if left untreated. Intriguingly, the easily observable retinal blood vessels can be used as a window to the heart and brain to allow judgement of microvascular damages in diseases such as diabetes or hypertension. The complex neuronal and endocrine interactions between heart, retina and brain have also been appreciated in myocardial infarction, ischemic stroke, and retinal diseases. To describe the intimate relationship between the individual tissues, we use the terms heart-brain and brain-retina axis in this review and focus on the role of transforming growth factor β (TGFβ) and neurotrophins in regulation of these axes under physiologic and pathologic conditions. Moreover, we particularly discuss their roles in inflammation and repair following ischemic/neovascular insults. As there is evidence that TGFβ signaling has the potential to regulate expression of neurotrophins, it is tempting to speculate, and is discussed here, that cross-talk between TGFβ and neurotrophin signaling protects cells from harmful and/or damaging events in the heart, retina, and brain.
Immunosenescence is considered a possible factor in the development of age-related macular degeneration and choroidal neovascularization (CNV). However, age-related changes of myeloid cells (MCs), such as microglia and macrophages, in the healthy retina or during CNV formation are ill-defined. In this study, Cx3cr1-positive MCs were isolated by fluorescence-activated cell sorting from six-week (young) and two-year-old (old) Cx3cr1\(^{GFP/+}\) mice, both during physiological aging and laser-induced CNV development. High-throughput RNA-sequencing was performed to define the age-dependent transcriptional differences in MCs during physiological aging and CNV development, complemented by immunohistochemical characterization and the quantification of MCs, as well as CNV size measurements. These analyses revealed that myeloid cells change their transcriptional profile during both aging and CNV development. In the steady state, senescent MCs demonstrated an upregulation of factors contributing to cell proliferation and chemotaxis, such as Cxcl13 and Cxcl14, as well as the downregulation of microglial signature genes. During CNV formation, aged myeloid cells revealed a significant upregulation of angiogenic factors such as Arg1 and Lrg1 concomitant with significantly enlarged CNV and an increased accumulation of MCs in aged mice in comparison to young mice. Future studies need to clarify whether this observation is an epiphenomenon or a causal relationship to determine the role of immunosenescence in CNV formation.
In patients with low-risk breast cancer, intraoperative radiotherapy (IORT) during breast-conserving surgery is a novel and convenient treatment option for delivering a single high dose of irradiation directly to the tumour bed. However, edema and fibrosis can develop after surgery and radiotherapy, which can subsequently impair quality of life. TGF-β is a strong inducer of the extracellular matrix component hyaluronan (HA). TGF-β expression and HA metabolism can be modulated by irradiation experimentally, and are involved in edema and fibrosis. We therefore hypothesized that IORT may regulate these factors.Wound fluid (WF) draining from breast lumpectomy sites was collected and levels of TGF-β1 and HA were determined by ELISA. Proliferation and marker expression was analyzed in primary lymphatic endothelial cells (LECs) treated with recombinant TGF-β or WF. Our results show that IORT does not change TGF-β1 or HA levels in wound fluid draining from breast lumpectomy sites, and does not lead to accumulation of sHA oligosaccharides. Nevertheless, concentrations of TGF-β1 were high in WF from patients regardless of IORT, at concentrations well above those associated with fibrosis and the suppression of LEC identity. Consistently, we found that TGF-β in WF is active and inhibits LEC proliferation. Furthermore, all three TGF-β isoforms inhibited LEC proliferation and suppressed LEC marker expression at pathophysiologically relevant concentrations.
Given that TGF-β contributes to edema and plays a role in the regulation of LEC identity, we suggest that inhibition of TGF-β directly after surgery might prevent the development of side effects such as edema and fibrosis.
Voltage-gated calcium channels (VGCCs) are widely distributed within the central nervous system (CNS) and presumed to play an important role in the pathophysiology of a broad spectrum of CNS disorders including Alzheimer’s and Parkinson’s disease as well as multiple sclerosis. Several calcium channel blockers have been in clinical practice for many years so that their toxicity and side effects are well studied. However, these drugs are primarily used for the treatment of cardiovascular diseases and most if not all effects on brain functions are secondary to peripheral effects on blood pressure and circulation. While the use of calcium channel antagonists for the treatment of CNS diseases therefore still heavily depends on the development of novel strategies to specifically target different channels and channel subunits, this review is meant to provide an impulse to further emphasize the importance of future research towards this goal.
Controversy surrounds neutrophil function in cancer because neutrophils were shown to provide both pro-and antitumor functions. We identified a heterogeneous subset of low-density neutrophils (LDNs) that appear transiently in self-resolving inflammation but accumulate continuously with cancer progression. LDNs display impaired neutrophil function and immunosuppressive properties, characteristics that are in stark contrast to those of mature, high-density neutrophils (HDNs). LDNs consist of both immature myeloid-derived suppressor cells (MDSCs) and mature cells that are derived from HDNs in a TGF-beta-dependent mechanism. Our findings identify three distinct populations of circulating neutrophils and challenge the concept that mature neutrophils have limited plasticity. Furthermore, our findings provide a mechanistic explanation to mitigate the controversy surrounding neutrophil function in cancer.
Das Naturschutzgebiet "Garchinger Heide" ist ein Relikt der ehemals ausgedehnten Kalkmagerrasen auf Pararendzinen über Niederterrassenschotter im Alpenvorland. Bei jahrhundertelanger extensiver Landnutzung hat sich auf trockenen nährstoffarmen Böden eine artenreiche Vegetation mit zahlreichen seltenen und gefährdeten Arten entwickelt. Die "Altheide", welche den größten Teil des Naturschutzgebiets einnimmt, ist geprägt durch flachgründige, nährstoffarme Böden, welche eine geschlossene Vegetation mit einem hohen Anteil an Arten der Halbtrockenrasen (hauptsächlich Mesobromion erecti und Cirsio-Brachypodion) tragen. Das 1945 durch Oberbodenabtrag begonnene, aber nicht mehr ausgebaute und verwendete „Rollfeld“ weist einen niedrigen Feinbodenanteil, welcher auf eine geringe Wasserverfügbarkeit schließen lässt, sowie niedrige Gehalte an Gesamtstickstoff und CAL-austauschbaren P2O5 auf. Die Vegetation ist lückig mit einem hohen Anteil an Trockenrasenarten (Xerobromion, Sedo-Scleranthetea, Sesleritalia albicantis). Das heutige Vorkommen zahlreicher Arten, welche in früheren Untersuchungen (1956 und 1986) nicht gefunden wurden, lässt auf eine fortschreitende Sukzession der Vegetation des Rollfeldes hin zu der der Altheide schließen. Der 1959 zum Naturschutzgebiet hinzu gekaufte ehemalige Acker unterscheidet sich immer noch deutlich von der Altheide. Eine allmähliche Annäherung der Standortbedingungen ist jedoch zu beobachten. So sanken die Gehalte an CAL-austauschbarem P_ 2 O_5 und K_2 O im Vergleich zu Werten aus dem Jahr 1993 deutlich ab. Trotz des immer noch hohen Anteils an Grünlandarten (Molinio-Arrhenatheretea) konnten sich im Vergleich zu 1986 mehr Magerrasenarten etablieren.
Background
The key for successful delivery in minimally-invasive hip replacement lies in the exact knowledge about the surgical anatomy. The minimally-invasive direct anterior approach to the hip joint makes it necessary to clearly identify the tensor fasciae latae muscle in order to enter the Hueter interval without damaging the lateral femoral cutaneous nerve. However, due to the inherently restricted overview in minimally-invasive surgery, this can be difficult even for experienced surgeons.
Methods and Surgical Technique
In this technical note, we demonstrate for the first time how to use the tensor fasciae latae perforator as anatomical landmark to reliably identify the tensor fasciae latae muscle in orthopaedic surgery. Such perforators are used for flaps in plastic surgery as they are constant and can be found at the lateral third of the tensor fasciae latae muscle in a direct line from the anterior superior iliac spine.
Conclusion
As demonstrated in this article, a simple knowledge transfer between surgical disciplines can minimize the complication rate associated with minimally-invasive hip replacement.
Primary structure is determined of an insertion of a clone isolated from the library of hypophyseal cDNA of cattle by hybridization with a probe specific for prolactin. Analysis of nucleotide sequences showed that in the process of cloning, reorganization occurred in structure of preprolactin cDNA, including an inversion of the 5'-terminal and deletion of the central section of cDNA. Nevertheless, from structure of cDNA, nucleotide sequences can be deduced of extended 5'- and 3'-terminal sections of preprolactin mRNA in cattle with lengths of 257 and 551 nucleotide residues, respectively. When these sequences are compared to those established previously, some differences were found in primary structure. The most important of them is the presence of an additional codon which codes alanine at the position (-22) of the signal peptide. It is suggested that heterogeneity of preprolactin mRNA of cattle in the section coding the signal peptide is the result of alternative splicing, as was shown for preprolactin mRNA in rats.
Peptide and polypeptide hormones represent an extensive group of biologically active compounds of important significance for medicine and agriculture. In recent years genetic engineering methods have been used to create strains of microorganisms synthesizing eukaryotic proteins, including hormones and their precursors. The first stage of such developments is the isolation of DNA coding the des~red product. We have accomplished the cloning of the cDNA of a number of polypeptide and peptide hormones of the pituitary of man and domestic animals. The model gene of human calcitonin has also been synthesized and cloned. The obtained genes are being used to develop methods for the microbiological synthesis of human and animal-hormones.
B cell aggregates in the central nervous system (CNS) have been associated with rapid disease progression in patients with multiple sclerosis (MS). Here we demonstrate a key role of carcinoembryogenic antigen-related cell adhesion molecule1 (CEACAM1) in B cell aggregate formation in MS patients and a B cell-dependent mouse model of MS. CEACAM1 expression was increased on peripheral blood B cells and CEACAM1\(^+\) B cells were present in brain infiltrates of MS patients. Administration of the anti-CEACAM1 antibody T84.1 was efficient in blocking aggregation of B cells derived from MS patients. Along these lines, application of the monoclonal anti-CEACAM1 antibody mCC1 was able to inhibit CNS B cell aggregate formation and significantly attenuated established MS-like disease in mice in the absence of any adverse effects. CEACAM1 was co-expressed with the regulator molecule T cell immunoglobulin and mucin domain −3 (TIM-3) on B cells, a novel molecule that has recently been described to induce anergy in T cells. Interestingly, elevated coexpression on B cells coincided with an autoreactive T helper cell phenotype in MS patients. Overall, these data identify CEACAM1 as a clinically highly interesting target in MS pathogenesis and open new therapeutic avenues for the treatment of the disease.
B cells have only recently begun to attract attention in the immunopathology of multiple sclerosis (MS). Suitable markers for the prediction of treatment success with immunomodulatory drugs are still missing. Here we evaluated the B cell response to brain antigens in n = 34 relapsing-remitting MS (RRMS) patients treated with glatiramer acetate (GA) using the enzyme-linked immunospot technique (ELISPOT). Our data demonstrate that patients can be subdivided into responders that show brain-specific B cell reactivity in the blood and patients without this reactivity. Only in patients that classified as B cell responders, there was a significant positive correlation between treatment duration and the time since last relapse in our study. This correlation was GA-specific because it was absent in a control group that consisted of interferon-\(\beta\) (IFN-\(\beta\))-treated RRMS patients (n = 23). These data suggest that GA has an effect on brain-reactive B cells in a subset of patients and that only this subset benefits from treatment. The detection of brain-reactive B cells is likely to be a suitable tool to identify drug responders.
Multiple sclerosis (MS) is an autoimmune disorder of the central nervous system (CNS) and characterized by the infiltration of immune cells, demyelination and axonal loss. Loss of axons and nerve fiber pathology are widely accepted as correlates of neurological disability. Hence, it is surprising that the development of neuroprotective therapies has been neglected for a long time. A reason for this could be the diversity of the underlying mechanisms, complex changes in nerve fiber pathology and the absence of biomarkers and tools to quantify neuroregenerative processes. Present therapeutic strategies are aimed at modulating or suppressing the immune response, but do not primarily attenuate axonal pathology. Yet, target-oriented neuroprotective strategies are essential for the treatment of MS, especially as severe damage of nerve fibers mostly occurs in the course of disease progression and cannot be impeded by immune modulatory drugs. This review shall depict the need for neuroprotective strategies and elucidate difficulties and opportunities.
In August 2004 the authors of this report undertook a survey on the Genus Oenothera (evening-primroses) in the valley of the river Main between the cities of Schweinfurt and Bamberg (Bavaria, Lower and Upper Franconia). 22 different taxa were identified, most of which are new to Bavaria, one new for Europe (Oenothera hazelae Gates) and another one new for Middle Europe (Oenothera stucchii Soldano). In this report a list of all Oenothera species found in Franconia is given and Oenothera stucchii, a particular tall (up to > 2 m) species with extremely long Hypanthia of 50-70 mm and fruit capsules with truncated teeth, is described and depicted in more detail.
LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy
(2018)
The potential of altering the tumor ECM to improve drug response remains fairly unexplored. To identify targets for modification of the ECM aiming to improve drug response and overcome resistance, we analyzed expression data sets from pre-treatment patient cohorts. Cross-evaluation identified a subset of chemoresistant tumors characterized by increased expression of collagens and collagen-stabilizing enzymes. We demonstrate that strong collagen expression and stabilization sets off a vicious circle of self-propagating hypoxia, malignant signaling, and aberrant angiogenesis that can be broken by an appropriate auxiliary intervention: Interfering with collagen stabilization by inhibition of lysyl oxidases significantly enhanced response to chemotherapy in various tumor models, even in metastatic disease. Inhibition of collagen stabilization by itself can reduce or enhance tumor growth depending on the tumor type. The mechanistical basis for this behavior is the dependence of the individual tumor on nutritional supply on one hand and on high tissue stiffness for FAK signaling on the other.
Summary
Here we describe a novel neuro-mesodermal assembloid model that recapitulates aspects of peripheral nervous system (PNS) development such as neural crest cell (NCC) induction, migration, and sensory as well as sympathetic ganglion formation. The ganglia send projections to the mesodermal as well as neural compartment. Axons in the mesodermal part are associated with Schwann cells. In addition, peripheral ganglia and nerve fibers interact with a co-developing vascular plexus, forming a neurovascular niche. Finally, developing sensory ganglia show response to capsaicin indicating their functionality.
The presented assembloid model could help to uncover mechanisms of human NCC induction, delamination, migration, and PNS development. Moreover, the model could be used for toxicity screenings or drug testing. The co-development of mesodermal and neuroectodermal tissues and a vascular plexus along with a PNS allows us to investigate the crosstalk between neuroectoderm and mesoderm and between peripheral neurons/neuroblasts and endothelial cells.
Highlights
•Novel neuro-mesodermal assembloid model of peripheral nervous system development
•Model covers neural crest cell induction, migration, and ganglion formation
•Ganglia send projections to the mesodermal as well as neural compartment
•Peripheral ganglia and nerve fibers interact with a co-developing vascular plexus
We demonstrated previously that phosphocholine and phosphocholine-modified macromolecules efficiently inhibit ATP-dependent release of interleukin-1β from human and murine monocytes by a mechanism involving nicotinic acetylcholine receptors (nAChR). Interleukin-1β is a potent pro-inflammatory cytokine of innate immunity that plays pivotal roles in host defence. Control of interleukin-1β release is vital as excessively high systemic levels cause life threatening inflammatory diseases. In spite of its structural similarity to acetylcholine, there are no other reports on interactions of phosphocholine with nAChR. In this study, we demonstrate that phosphocholine inhibits ion-channel function of ATP receptor P2X7 in monocytic cells via nAChR containing α9 and α10 subunits. In stark contrast to choline, phosphocholine does not evoke ion current responses in Xenopus laevis oocytes, which heterologously express functional homomeric nAChR composed of α9 subunits or heteromeric receptors containing α9 and α10 subunits. Preincubation of these oocytes with phosphocholine, however, attenuated choline-induced ion current changes, suggesting that phosphocholine may act as a silent agonist. We conclude that phophocholine activates immuno-modulatory nAChR expressed by monocytes but does not stimulate canonical ionotropic receptor functions.
Die Verbreitung der Gattung Chamaesyce auf den Friedhöfen des Landkreises Main-Spessart, Bayern
(2010)
Während der Jahre 2003 bis 2007 wurden Vorkommen und Verbreitung der Gattung Chamaesyce auf 126 Friedhöfen des Landkreises Main-Spessart untersucht. Drei Arten, C. humifusa, C. maculata und C. prostrata, konnten nachgewiesen werden. Bevorzugte Wuchsorte sind neben Bahnhöfen, botanischen Gärten und Gärtnereien vor allem Friedhöfe. Auf den untersuchten 126 Friedhöfen des Main-Spessart-Kreises wuchsen die Chamaesyce-Arten auf Kies- und Sandwegen, in Pflaster- und Plattenfugen, auf Gräbern und Beeten. C. humifusa wurde auf 27, C. maculata auf 46 und C. prostrata auf einem der 126 Friedhöfe des Untersuchungsgebietes gefunden.
Early treatment with glucocorticoids could help reduce both cytotoxic and vasogenic edema, leading to improved clinical outcome after stroke. In our previous study, isosteviol sodium (STVNA) demonstrated neuroprotective effects in an in vitro stroke model, which utilizes oxygen-glucose deprivation (OGD). Herein, we tested the hypothesis that STVNA can activate glucocorticoid receptor (GR) transcriptional activity in brain microvascular endothelial cells (BMECs) as previously published for T cells. STVNA exhibited no effects on transcriptional activation of the glucocorticoid receptor, contrary to previous reports in Jurkat cells. However, similar to dexamethasone, STVNA inhibited inflammatory marker IL-6 as well as granulocyte-macrophage colony-stimulating factor (GM-CSF) secretion. Based on these results, STVNA proves to be beneficial as a possible prevention and treatment modality for brain ischemia-reperfusion injury-induced blood–brain barrier (BBB) dysfunction.
Recombinant beta interferons-1 (IFNβ-1) are used as first line therapies in patients with relapsing multiple sclerosis (MS), a chronic inflammatory and neurodegenerative disease of the CNS. IFNβ-1a/b has moderate effects on the prevention of relapses and slowing of disease progression. Fibroblast growth factors (FGFs) and FGF receptors (FGFRs) are known to play a key role in the pathology of MS and its model EAE. To investigate the effects of short-term treatment with s.c. IFNβ-1a versus the combined application of s.c. IFNβ-1a and oligodendrocyte-specific deletion of FGFR1 (Fgfr1\(^{ind−/−}\) mice) in MOG\(_{35-55}\)-induced EAE. IFNβ-1a (30 mg/kg) was applied s.c. from days 0–7 p.i. of EAE in controls and Fgfr1\(^{ind−/−}\) mice. FGFR signaling proteins associated with inflammation/degeneration in MS/EAE were analyzed by western blot in the spinal cord. Further, FGFR1 in Oli-neu oligodendrocytes were inhibited by PD166866 and treated with IFNβ-1a (400 ng/mL). Application of IFNβ-1a over 8 days resulted in less symptoms only at the peak of disease (days 9–11) compared to controls. Application of IFNβ-1a in Fgfr1\(^{ind−/−}\) mice resulted in less symptoms primarily in the chronic phase of EAE. Fgfr1\(^{ind−/−}\) mice treated with IFNβ-1a showed increased expression of pERK and BDNF. In Oli-neu oligodendrocytes, treatment with PD166866 and IFNβ-1a also showed an increased expression of pERK and BDNF/TrkB. These data suggest that the beneficial effects in the chronic phase of EAE and on signaling molecules associated with ERK and BDNF expression are caused by the modulation of FGFR1 and not by interferon beta-1a. FGFR may be a potential target for therapy in MS.
Multiple sclerosis (MS) is a chronic inflammatory and degenerative disease of the central nervous system (CNS). MS commonly affects the cerebellum causing acute and chronic symptoms. Cerebellar signs significantly contribute to clinical disability, and symptoms such as tremor, ataxia, and dysarthria are difficult to treat. Fibroblast growth factors (FGFs) and their receptors (FGFRs) are involved in demyelinating pathologies such as MS. In autopsy tissue from patients with MS, increased expression of FGF1, FGF2, FGF9, and FGFR1 was found in lesion areas. Recent research using mouse models has focused on regions such as the spinal cord, and data on the expression of FGF/FGFR in the cerebellum are not available. In recent EAE studies, we detected that oligodendrocyte-specific deletion of FGFRs results in a milder disease course, less cellular infiltrates, and reduced neurodegeneration in the spinal cord. The objective of this study was to characterize the role of FGFR1 in oligodendrocytes in the cerebellum. Conditional deletion of FGFR1 in oligodendrocytes (Fgfr1\(^{ind−/−}\) was achieved by tamoxifen application, EAE was induced using the MOG\(_{35-55}\) peptide. The cerebellum was analyzed by histology, immunohistochemistry, and western blot. At day 62 p.i., Fgfr1\(^{ind−/−}\) mice showed less myelin and axonal degeneration compared to FGFR1-competent mice. Infiltration of CD3(+) T cells, Mac3(+) cells, B220(+) B cells and IgG(+) plasma cells in cerebellar white matter lesions (WML) was less in Fgfr1\(^{ind−/−}\)mice. There were no effects on the number of OPC or mature oligodendrocytes in white matter lesion (WML). Expression of FGF2 and FGF9 associated with less myelin and axonal degeneration, and of the pro-inflammatory cytokines IL-1β, IL-6, and CD200 was downregulated in Fgfr1\(^{ind−/−}\) mice. The FGF/FGFR signaling protein pAkt, BDNF, and TrkB were increased in Fgfr1\(^{ind−/−}\) mice. These data suggest that cell-specific deletion of FGFR1 in oligodendrocytes has anti-inflammatory and neuroprotective effects in the cerebellum in the EAE disease model of MS.
Multiple sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the central nervous system (CNS) affecting more than two million people worldwide. In MS, oligodendrocytes and myelin sheaths are destroyed by autoimmune-mediated inflammation, while remyelination is impaired. Recent investigations of post-mortem tissue suggest that Fibroblast growth factor (FGF) signaling may regulate inflammation and myelination in MS. FGF2 expression seems to correlate positively with macrophages/microglia and negatively with myelination; FGF1 was suggested to promote remyelination. In myelin oligodendrocyte glycoprotein (MOG)\(_{35–55}\)-induced experimental autoimmune encephalomyelitis (EAE), systemic deletion of FGF2 suggested that FGF2 may promote remyelination. Specific deletion of FGF receptors (FGFRs) in oligodendrocytes in this EAE model resulted in a decrease of lymphocyte and macrophage/microglia infiltration as well as myelin and axon degeneration. These effects were mediated by ERK/Akt phosphorylation, a brain-derived neurotrophic factor, and downregulation of inhibitors of remyelination. In the first part of this review, the most important pharmacotherapeutic principles for MS will be illustrated, and then we will review recent advances made on FGF signaling in MS. Thus, we will suggest application of FGFR inhibitors, which are currently used in Phase II and III cancer trials, as a therapeutic option to reduce inflammation and induce remyelination in EAE and eventually MS.